Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease

被引:95
|
作者
Yamazaki, K
Takazoe, M
Tanaka, T
Ichimori, T
Saito, S
Iida, A
Onouchi, Y
Hata, A
Nakamura, Y
机构
[1] Univ Tokyo, Inst Med Sci, Mol Med Lab, Tokyo 1088639, Japan
[2] Social Insurance Cent Gen Hosp, Div Gastroenterol, Dept Med, Tokyo, Japan
[3] Suzaki Kuroshio Hosp, Div Gastroenterol, Dept Med, Kouchi, Japan
[4] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Genotyping, Kanagawa, Japan
[5] RIKEN, Inst Phys & Chem Res, SNP Res Ctr, Lab Gastrointestinal Dis, Kanagawa, Japan
关键词
Crohn disease; single-nucleotide polymorphism (SNP); DLG5; SLC22A4; SLC22A5; OCTN1; OCTN2; Japanese population;
D O I
10.1007/s10038-004-0204-x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Crohn disease (CD) is an inflammatory bowel disease characterized by chronic transmural, segmental, and typically granulomatous inflammation of the gut. Recently, two novel candidate gene loci associated with CD, SLC22A4 and SLC22A5 on chromosome 5 known as IBD5 and DLG5 on chromosome 10, were identified through association analysis of Caucasian CD patients. We validated these candidate genes in Japanese patients with CD and found a weak but possible association with both SLC22A4 (P=0.028) and DLG5 (P=0.023). However, the reported genetic variants that were indicated to be causative in the Caucasian population were completely absent in or were not associated with Japanese CD patients. These findings imply significant differences in genetic background with CD susceptibility among different ethnic groups and further indicate some difficulty Of population-based studies.
引用
收藏
页码:664 / 668
页数:5
相关论文
共 50 条
  • [21] Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment
    Monika Jaruskova
    Nikola Curik
    Rajna Hercog
    Vaclava Polivkova
    Eliska Motlova
    Vladimir Benes
    Hana Klamova
    Pavla Pecherkova
    Petra Belohlavkova
    Filip Vrbacky
    Katerina Machova Polakova
    Journal of Experimental & Clinical Cancer Research, 36
  • [22] Plasma carnitine ester profiles in Crohn's disease patients characterized for SLC22A4 C1672T and SLC22A5 G-207C genotypes
    Bene, Judit
    Komlosi, Katalin
    Magyari, Lili
    Talian, Gabor
    Horvath, Krisztina
    Gasztonyi, Beata
    Miheller, Pai
    Figler, Maria
    Mozsik, Gyula
    Tulassay, Zsolt
    Melegh, Bela
    BRITISH JOURNAL OF NUTRITION, 2007, 98 (02) : 345 - 350
  • [23] Does genetic variation within the SLC22A4 and SLC22A5 (OCTN1 and 2) genes fully describe the contribution of the IBD5 locus to the risk of Crohn's Disease?
    Onnie, C
    Fisher, S
    Hampe, J
    Mirza, M
    Forbes, A
    Mansfield, J
    Sanderson, J
    Lewis, C
    Schreiber, S
    Mathew, C
    GASTROENTEROLOGY, 2005, 128 (04) : A446 - A446
  • [24] Association of SLC22A4/5 polymorphisms with steroid responsiveness of inflammatory Bowel disease in Japan
    Nakahara, Seiya
    Arimura, Yoshiaki
    Saito, Katsuhiko
    Goto, Akira
    Motoya, Satoshi
    Shinomura, Yasuhisa
    Miyamoto, Atsushi
    Imai, Kohzoh
    DISEASES OF THE COLON & RECTUM, 2008, 51 (05) : 598 - 603
  • [25] Characterization of Placental SLC22A4 (OCTN1) and SLC22A5 (OCTN2) Expression: Influence of Genotype and Gestation Age
    Grube, Markus
    Reuther, Sebastian
    Koeck, Kathleen
    Salje, Karen
    Siegmund, Werner
    Kroemer, Heyo K.
    DRUG METABOLISM REVIEWS, 2010, 42 : 318 - 318
  • [26] Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: Gain-of-function by interchange of selected amino acids
    Bacher, Petra
    Giersiefer, Susanne
    Bach, Markus
    Fork, Christian
    Schoemig, Edgar
    Gruendemann, Dirk
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (12): : 2594 - 2602
  • [27] Prevalence of SLC22A4, SLC22AS and CARD15 gene mutations in Hungarian pediatric patients with Crohn's disease
    Bene, Judit
    Magyari, Lili
    Talian, Gabor
    Komlosi, Katalin
    Gasztonyi, Beata
    Tari, Beata
    Varkonyi, Agnes
    Mozsik, Gyula
    Melegh, Bela
    WORLD JOURNAL OF GASTROENTEROLOGY, 2006, 12 (34) : 5550 - 5553
  • [28] Functional Genetic Variation in the Basal Promoter of the Organic Cation/Carnitine Transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)
    Tahara, Harunobu
    Yee, Sook Wah
    Urban, Thomas J.
    Hesselson, Stephanie
    Castro, Richard A.
    Kawamoto, Michiko
    Stryke, Doug
    Johns, Susan J.
    Ferrin, Thomas E.
    Kwok, Pui-Yan
    Giacomini, Kathleen M.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2009, 329 (01): : 262 - 271
  • [29] FUNCTIONAL GENETIC VARIATION IN THE BASAL PROMOTER OF THE ORGANIC CATION/CARNITINE TRANSPORTERS, OCTN1 (SLC22A4) AND OCTN2 (SLC22A5)
    Tahara, H.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 : S49 - S49
  • [30] Relationship between CARD15, SLC22A4/5, and DLG5 polymorphisms and early-onset inflammatory bowel diseases:: An Italian multicentric study
    Ferraris, A
    Torres, B
    Knafelz, D
    Barabino, A
    Lionetti, P
    de Angelis, GL
    Iacono, G
    Papadatou, B
    D'Amato, G
    Di Cionmo, V
    Dallapiccola, BI
    Castro, M
    INFLAMMATORY BOWEL DISEASES, 2006, 12 (05) : 355 - 361